Reilly Clark

Managing Associate

Boston

Reilly is a managing associate in the Boston office and a member of Orrick's Technology Companies Group.

Reilly focuses on representing  high growth technology and life sciences companies through their business life cycle. He advises on a broad range of corporate and transactional matters from formation to exit, including incorporation, governance, financing, and M&A matters. Reilly regularly counsels clients on both venture capital transactions as well as day-to-day governance and equity compensation matters.

Prior to joining Orrick, Reilly worked with Wilson Sonsini Goodrich & Rosati in its Boston office and served in the United States Marine Corps.

    • Doron Therapeutics in its $11M Series A financing led by SPRIM Global Investments
    • Clear Future on its acquisition of FC2 Female Condom.
    • Fluent BioSciences in multiple rounds of financings led by Samsara Capital and Illumina Ventures and in its sale to Illumina
    • NTx in its $47.5M Series B financing led by RA Capital
    • Glyphic BioTechnologies in its launch and Series A financing led by OMX Ventures
    • Time BioVentures in various investments.
    • Harbour Food Service Equipment on its sale to Imperial Dade.
    • ArrePath in its $20M Seed Financing led by Boehringer Ingelheim Venture Fund, Insight Partners and Innospark Ventures
    • Iterative Scopes in its $150M Series B financing led by Insight Partners and Clearlake Capital
    • FREYR in its SPAC transaction with Alussa Energy

    Please note: Reilly's experience includes that prior to joining Orrick.